{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:57:08Z","timestamp":1788155828948,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["28893"],"award-info":[{"award-number":["28893"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejca.2025.116061","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:42:57Z","timestamp":1760852577000},"page":"116061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4649-2034","authenticated-orcid":false,"given":"Emanuele","family":"Crocetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2053-7078","authenticated-orcid":false,"given":"Damien","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-0700","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Jooste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-2904","authenticated-orcid":false,"given":"Silvia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-200X","authenticated-orcid":false,"given":"Luigino Dal","family":"Maso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9824-3657","authenticated-orcid":false,"given":"Rafael","family":"Marcos-Gragera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-150X","authenticated-orcid":false,"given":"Stephanie","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-1351","authenticated-orcid":false,"given":"Tina","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6863-9992","authenticated-orcid":false,"given":"Xavier","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4134-1410","authenticated-orcid":false,"given":"Alexandra","family":"Mayer-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2877-8757","authenticated-orcid":false,"given":"Laetitia","family":"Daubisse-Marliac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-1554","authenticated-orcid":false,"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-0757","authenticated-orcid":false,"given":"Maria-Jos\u00e9","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3537-6799","authenticated-orcid":false,"given":"Mohsen","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ziliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.116061_bib1","unstructured":"ECIS - European Cancer Information System. From \u3008https:\/\/ecis.jrc.ec.europa.eu\u3009, accessed on 02\/01\/2024 \u00a9 European Union, 2024,"},{"key":"10.1016\/j.ejca.2025.116061_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2023.03.019","article-title":"Survival in melanoma in the nordic countries into the era of targeted and immunological therapies","volume":"186","author":"Tichanek","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116061_bib3","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3390\/cancers14102441","article-title":"Cancer survival in adults in Spain: a Population-Based study of the spanish network of cancer registries (REDECAN)","volume":"14","author":"Guevara","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejca.2025.116061_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaad.2018.09.018","article-title":"A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype","volume":"80","author":"Brunssen","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116061_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bjd.21051","article-title":"The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population-based investigation","volume":"187","author":"Zamagni","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2025.116061_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2021.06.007","article-title":"Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003-2018): a nationwide population-based study","volume":"154","author":"Leeneman","year":"2021","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2025.116061_bib7","first-page":"45","article-title":"Longer survival from melanoma in Germany: a registry-based time series study","volume":"121","author":"Eisemann","year":"2024","journal-title":"Dtsch Arztebl"},{"issue":"6","key":"10.1016\/j.ejca.2025.116061_bib8","doi-asserted-by":"crossref","first-page":"pkaa078","DOI":"10.1093\/jncics\/pkaa078","article-title":"Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (Concord-3)","volume":"4","author":"Di Carlo","year":"2020","journal-title":"JNCI Cancer Spectr"},{"issue":"5","key":"10.1016\/j.ejca.2025.116061_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1684\/ejd.2021.4136","article-title":"Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor","volume":"31","author":"Rubi\u00f3-Casadevall","year":"2021","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2025.116061_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjd.21750","article-title":"Melanoma overdiagnosis: why it matters and what can be done about it","volume":"187","author":"Bell","year":"2022","journal-title":"Br J Dermatol"},{"issue":"15","key":"10.1016\/j.ejca.2025.116061_bib11","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2015.07.039","article-title":"Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study","volume":"51","author":"Crocetti","year":"2015","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.116061_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/0284186X.2016.1243804","article-title":"Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study","volume":"56","author":"Padrik","year":"2017","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2025.116061_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jdv.18960","article-title":"Significant improvement in melanoma survival over the last decade: a Hungarian nationwide study between 2011 and 2019","volume":"37","author":"Liszkay","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.ejca.2025.116061_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-4.15334","article-title":"Burden of malignant melanoma in Ukraine in 2002-2013: incidence, mortality and survival","volume":"42","author":"Korovin","year":"2020","journal-title":"Exp Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2025.116061_bib15","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.3390\/ijerph18084165","article-title":"Trends in incidence and mortality of skin melanoma in Lithuania 1991-2015","volume":"18","author":"Dulskas","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"23","key":"10.1016\/j.ejca.2025.116061_bib16","doi-asserted-by":"crossref","first-page":"16118","DOI":"10.3390\/ijerph192316118","article-title":"Mortality trends due to skin melanoma in Poland in the years 2000-2020","volume":"19","author":"Dziankowska-Zaborszczyk","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.ejca.2025.116061_bib17","article-title":"Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor","volume":"10","author":"Forsea","year":"2020","journal-title":"Dermatol Pr Concept"},{"key":"10.1016\/j.ejca.2025.116061_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.canep.2018.08.010","article-title":"EUROCARE-5 working group survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study","volume":"56","author":"Stiller","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2025.116061_bib19","series-title":"International Classification of Diseases for Oncology (ICD-O)","year":"2000"},{"key":"10.1016\/j.ejca.2025.116061_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.2002.20.3.826","article-title":"Up-to-date long-term survival curves of patients with cancer by period analysis","volume":"20","author":"Brenner","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.116061_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejca.2003.10.013","article-title":"Period analysis for \u2018up-todate\u2019 cancer survival data: theory, empirical evaluation, computational realisation and applications","volume":"40","author":"Brenner","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116061_bib22","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116061_bib23","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2023 Apr 19. [updated: 2023 Nov 16; cited 2024 Feb 20]. Available from: \u3008https:\/\/seer.cancer.gov\/statistics-network\/explorer\/\u3009. Data source(s): SEER Incidence Data, November 2022 Submission (1975-2020), SEER 22 registries (excluding Illinois and Massachusetts). Expected Survival Life Tables by Socio-Economic Standards."},{"key":"10.1016\/j.ejca.2025.116061_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102321","article-title":"Twenty years of melanoma in Victoria, Queensland, and South Australia (1997 \u2013 2016)","volume":"83","author":"Venugopal","year":"2023","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.ejca.2025.116061_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjd.21274","article-title":"Concord working group. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1\u200a578\u200a482 adults diagnosed during 2000-2014 in 59 countries (Concord-3)","volume":"187","author":"Di Carlo","year":"2022","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.ejca.2025.116061_bib26","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/ijc.33479","article-title":"Skin melanoma deaths within 1 or 3 years from diagnosis in Europe","volume":"148","author":"Sacchetto","year":"2021","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.116061_bib27","first-page":"10","article-title":"Epidemiology of melanoma in the Czech Republic in east bohemia in the period 2002-2017 and the effect of the annual sunshine exposure","volume":"63","author":"\u010celakovsk\u00e1","year":"2020","journal-title":"Acta Med (Hrad Kral)"},{"key":"10.1016\/j.ejca.2025.116061_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113980","article-title":"Survival trends for patients diagnosed with cutaneous malignant melanoma in the nordic countries 1990-2016: the NORDCAN survival studies","volume":"202","author":"Lundberg","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116061_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115213","article-title":"Concord working group. Sex differences in survival from melanoma of the skin: the role of age, anatomic location and stage at diagnosis: a Concord-3 study in 59 countries","volume":"217","author":"Di Carlo","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116061_bib30","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.3390\/ijerph18157945","article-title":"Gender-Dependent specificities in cutaneous melanoma predisposition, risk factors, somatic mutations, prognostic and predictive factors: a systematic review","volume":"18","author":"D\u2019Ecclesiis","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.ejca.2025.116061_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/bjd\/ljad365","article-title":"Assessing the genetic risk of nodular melanoma using a candidate gene approach","volume":"190","author":"Stark","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2025.116061_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2017.12.024","article-title":"Trends in incidence of thick, thin and in situ melanoma in Europe","volume":"92","author":"Sacchetto","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116061_bib33","first-page":"372","article-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018","volume":"1","author":"Defossez","year":"2019"},{"key":"10.1016\/j.ejca.2025.116061_bib34","unstructured":"Andreano A., Buzzoni C., Guzzinati S., Russo A.G. I TUMORI IN ITALIA Trend 2003-2014. Available at Accessed on 21\/02\/2024 \u3008https:\/\/www.registri-tumori.it\/cms\/sites\/default\/files\/pubblicazioni\/MONOGRAFIA_TREND_2003_2014.pdf\u3009."},{"key":"10.1016\/j.ejca.2025.116061_bib35","doi-asserted-by":"crossref","first-page":"w20388","DOI":"10.4414\/smw.2020.20388","article-title":"37-year incidence and mortality time trends of common cancer types by sex, age, and stage in the canton of zurich","volume":"150","author":"Wanner","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ejca.2025.116061_bib36","unstructured":"IKNL the Netherlands Comprehensive Cancer Organisation\u3008https:\/\/iknl.nl\/en\u3009\u200b\u200b\u200b\u200bAccessed on 21\/02\/2024."},{"key":"10.1016\/j.ejca.2025.116061_bib37","series-title":"Association of the Nordic Cancer Registries","article-title":"NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries, version 9.3 (02.10.2023)","author":"Lar\u00f8nningen","year":"2023"},{"issue":"3","key":"10.1016\/j.ejca.2025.116061_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1470-2045(23)00646-0","article-title":"Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study","volume":"25","author":"De Angelis","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116061_bib39","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","author":"Robert","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2025.116061_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114074","article-title":"Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them","volume":"204","author":"Garbe","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.116061_bib41","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/healthcare10091618","article-title":"How can the EU beating cancer plan help in tackling lung cancer, colorectal cancer, breast cancer and meanoma?","volume":"10","author":"Horgan","year":"2022","journal-title":"Healthcare"},{"issue":"6","key":"10.1016\/j.ejca.2025.116061_bib42","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/annonc\/mdt030","article-title":"EUROCARE working group. Cancer prevalence estimates in Europe at the beginning of 2000","volume":"24","author":"Gatta","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.116061_bib43","series-title":"Global cancer observatory: cancer tomorrow","author":"Ferlay","year":"2024"},{"issue":"5","key":"10.1016\/j.ejca.2025.116061_bib44","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ije\/dyaa128","article-title":"Cancer cure for 32 cancer types: results from the EUROCARE-5 study","volume":"49","author":"Dal Maso","year":"2020","journal-title":"Int J Epidemiol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925009475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925009475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:08:28Z","timestamp":1773814108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925009475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S0959804925009475"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116061","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116061"}}